Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.



Signify Premium Insight: Tumour Boards and the Burden of Proof

Signify Premium Insights Subscription Required

29th June 2021 – Specialist tumour board software may hold great potential to make cancer care more efficient and give patients better outcomes, but, will providers be willing to pay for it?

Teleradiology Read Volumes Drop 22% in 2020, But Rapid Bounce Back Already Well Underway

29th June 2021 – When will demand for teleradiology services return to pre-pandemic levels and what will drive the bounce back? Here we explore six key drivers that will reverse the trend seen in 2020.

Signify Premium Insight: Sectra Goes in Early on Multidisciplinary AI Marketplaces with Pathology Play

Signify Premium Insights Subscription Required

25th June, 2021 – Sectra has added digital pathology tools to its Amplifier AI marketplace. This Premium Insight explores the prospects for such a move and asks whether it will help the Swedish vendor better exploit the growing momentum for digitalisation in pathology.

Signify Premium Insight: Philips and Elekta See Promise in Partnership

Signify Premium Insights Subscription Required

23rd June, 2021 – Philips and Elekta have announced a strengthening of their well-established partnership. Such a move will allow the two vendors to better integrate their products and offer providers a more complete package, but will it be enough to challenge Siemens Healthineers, and its Varian acquisition?

Exscientia’s $525m Funding Signals Bullish Outlook for AI in Drug Development and Clinical Trials

17th June 2021 – Signify Research examines the top four questions VC investment firms should be asking themselves before committing to an investment.